Media headlines about Capnia (NASDAQ:SLNO) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Capnia earned a coverage optimism score of 0.24 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.0042999722475 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
A number of research firms recently weighed in on SLNO. Maxim Group restated a “buy” rating and issued a $25.00 price objective on shares of Capnia in a report on Wednesday, September 13th. ValuEngine upgraded Capnia from a “strong sell” rating to a “sell” rating in a report on Friday, October 6th.
Shares of Capnia (NASDAQ SLNO) traded down $0.02 during trading on Tuesday, reaching $2.07. The company’s stock had a trading volume of 34,900 shares, compared to its average volume of 24,356. Capnia has a 52-week low of $1.47 and a 52-week high of $6.60.
Capnia (NASDAQ:SLNO) last issued its quarterly earnings results on Friday, August 11th. The company reported ($0.30) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.10. Capnia had a negative return on equity of 69.67% and a negative net margin of 1,389.76%.
ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Capnia (SLNO) Share Price” was reported by Stock Observer and is the property of of Stock Observer. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thestockobserver.com/2017/11/15/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-capnia-slno-share-price.html.
Capnia Company Profile
Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.
Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with MarketBeat.com's FREE daily email newsletter.